Insider Trading & Ownership of Claire Poll

Location
London, United Kingdom
Summary
The estimated net worth of Claire Poll is at least $56,008,140 dollars as of 05 Feb 2024. Claire Poll is the General Counsel of Verona Pharma plc and owns shares of Verona Pharma plc stock worth about $56.01M.
Signature
/s/ Claire Poll
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Claire Poll and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Claire Poll has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $56,008,140.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Verona Pharma plc ($56,008,140).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Claire Poll

Insider Transactions Reported by Claire Poll:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .